Page 5 - Read Online

Hepatoma Research
CONTENTS

Topic: SBRT and Immunotherapy for the Management of HCC: A Recent
Appraisal

1 Immune checkpoint blockade therapies for HCC: current status and future implications
Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford, Aparna Jayachandran
Hepatoma Res 2019;5:32 http://dx.doi.org/10.20517/2394-5079.2019.24

2 Cytotoxic immune cell-based immunotherapy for hepatocellular carcinoma
Jing Li, Longxiang Tao, Xuefu Wang
Hepatoma Res 2020;6:15 http://dx.doi.org/10.20517/2394-5079.2019.34

3 Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related
hepatocellular carcinoma
Morteza Hafezi, Antonio Bertoletti, Anthony Tan
Hepatoma Res 2020;6:23 http://dx.doi.org/10.20517/2394-5079.2020.02

4 Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular
carcinoma
Wei Qin, Zhen-Yu Cao, Si-Yuan Liu, Xun-Di Xu
Hepatoma Res 2020;6:24 http://dx.doi.org/10.20517/2394-5079.2020.04

5 The advancement of immunotherapy in hepatocellular carcinoma
Ling Ni, Yu Feng, Chen Dong
Hepatoma Res 2020;6:25 http://dx.doi.org/10.20517/2394-5079.2020.14

6 Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma
Xiao-Jia Song, Chun-Hong Ma
Hepatoma Res 2020;6:27 http://dx.doi.org/10.20517/2394-5079.2020.05

7 Conventional type 1 dendritic cells in protective antitumor immunity and its potential in
hepatocellular carcinoma
Chunfeng Qu, Kun Chen, Shao-Yan Cheng
Hepatoma Res 2020;6:38 http://dx.doi.org/10.20517/2394-5079.2020.12

8 Stereotactic body radiation therapy for the management of HCC
Jia-Xin Li, Hong Wu, Yong Zeng
Hepatoma Res 2020;6:39 http://dx.doi.org/10.20517/2394-5079.2020.13

9 The advances in immunotherapy for hepatocellular carcinoma
Fan Zhang, Yumin Li
Hepatoma Res 2020;6:40 http://dx.doi.org/10.20517/2394-5079.2020.20